Indiana Launches BioHeartland Brand to Unify $125 Billion Bioscience Ecosystem

Industry
โดย PR Newswire·Read original
Summary · why it matters

Indiana's bioscience sector has been rebranded as BioHeartland Indiana, a new unified identity announced at the BIO International Convention in San Diego. The initiative brings together the state's strengths in human health, animal health, and plant science across an ecosystem that generates more than $125 billion in annual economic impact. The region is home to global leaders Eli Lilly, Elanco Animal Health, and Corteva, and its biosciences sector contributes over $100 billion of economic activity to the state. The announcement follows Governor Mike Braun's $1 billion commitment to help life sciences companies accelerate growth over the next ten years. BioHeartland Indiana is led by the CEOs of Central Indiana Corporate Partnership in collaboration with BioCrossroads and AgriNovus Indiana.

Impact on stocks 3

Synthetic Biology (non-pharma)▲ · 1 stocks
Corteva Inc
CTVA
▲ PositiveRegulationrelevance

State branding and $1B commitment may support bioscience growth, benefiting Corteva as a plant science leader in Indiana.

Health Care▲ · 1 stocks
Elanco Animal Health
ELAN
▲ PositiveRegulationrelevance

State branding and $1B commitment may support bioscience growth, benefiting Elanco as an animal health leader in Indiana.

Biotech & Genomic Medicine▲ · 1 stocks
Eli Lilly and Company
LLY
▲ PositiveRegulationrelevance

State branding and $1B commitment may support bioscience growth, benefiting Eli Lilly as a human health leader in Indiana.

© 2026 MarketDXNews